Annual Long Term Debt
$2.52 B
-$217.60 M-7.94%
31 December 2023
Summary:
Amneal Pharmaceuticals annual long term debt is currently $2.52 billion, with the most recent change of -$217.60 million (-7.94%) on 31 December 2023. During the last 3 years, it has fallen by -$364.55 million (-12.63%). AMRX annual long term debt is now -12.63% below its all-time high of $2.89 billion, reached on 31 December 2020.AMRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.26 B
-$9.85 M-0.43%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly long term debt is currently $2.26 billion, with the most recent change of -$9.85 million (-0.43%) on 30 September 2024. Over the past year, it has dropped by -$418.54 million (-15.60%). AMRX quarterly long term debt is now -22.81% below its all-time high of $2.93 billion, reached on 31 March 2020.AMRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.9% | -15.6% |
| 3 y3 years | -12.6% | -20.3% |
| 5 y5 years | -5.5% | -17.2% |
AMRX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -12.6% | at low | -20.3% | at low |
| 5 y | 5 years | -12.6% | at low | -22.8% | at low |
| alltime | all time | -12.6% | +80.8% | -22.8% | +62.2% |
Amneal Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.26 B(-0.4%) |
| June 2024 | - | $2.27 B(-9.7%) |
| Mar 2024 | - | $2.52 B(-0.2%) |
| Dec 2023 | $2.52 B(-7.9%) | $2.52 B(-5.9%) |
| Sept 2023 | - | $2.68 B(-0.4%) |
| June 2023 | - | $2.69 B(-0.6%) |
| Mar 2023 | - | $2.71 B(-1.2%) |
| Dec 2022 | $2.74 B(-3.2%) | $2.74 B(-0.4%) |
| Sept 2022 | - | $2.75 B(-0.6%) |
| June 2022 | - | $2.77 B(-1.9%) |
| Mar 2022 | - | $2.82 B(-0.4%) |
| Dec 2021 | $2.83 B | $2.83 B(-0.3%) |
| Sept 2021 | - | $2.84 B(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $2.87 B(-0.1%) |
| Mar 2021 | - | $2.88 B(-0.3%) |
| Dec 2020 | $2.89 B(+5.7%) | $2.89 B(-0.9%) |
| Sept 2020 | - | $2.92 B(-0.4%) |
| June 2020 | - | $2.93 B(-0.2%) |
| Mar 2020 | - | $2.93 B(+7.3%) |
| Dec 2019 | $2.73 B(+2.4%) | $2.73 B(-0.1%) |
| Sept 2019 | - | $2.73 B(-0.4%) |
| June 2019 | - | $2.74 B(-0.3%) |
| Mar 2019 | - | $2.75 B(+3.2%) |
| Dec 2018 | $2.67 B(+91.3%) | $2.67 B(-0.2%) |
| Sept 2018 | - | $2.68 B(-0.2%) |
| June 2018 | - | $2.68 B(+92.1%) |
| Dec 2017 | $1.40 B | $1.40 B |
FAQ
- What is Amneal Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual long term debt year-on-year change?
- What is Amneal Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly long term debt year-on-year change?
What is Amneal Pharmaceuticals annual long term debt?
The current annual long term debt of AMRX is $2.52 B
What is the all time high annual long term debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual long term debt is $2.89 B
What is Amneal Pharmaceuticals annual long term debt year-on-year change?
Over the past year, AMRX annual long term debt has changed by -$217.60 M (-7.94%)
What is Amneal Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AMRX is $2.26 B
What is the all time high quarterly long term debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly long term debt is $2.93 B
What is Amneal Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, AMRX quarterly long term debt has changed by -$418.54 M (-15.60%)